VN

Vietnam

1267 clinical trials

Find Trials

Clinical Trials (1267)

Showing 20 of 1,267 trialsScroll for more
NCT04175600Phase 34 sites

A Study of Selexipag as Add-On Treatment to Standard of Care in Children With Pulmonary Arterial Hypertension

Active Not Recruiting
NCT05179876Phase 33 sites

A Study Providing Treatment Access in Participants With Pulmonary Hypertension Completing a Parent Study and Having no Other Option

Recruiting
NCT07088926Phase 26 sites

A Study to Evaluate the Efficacy, Safety, and PK of AZD0292 Administered IV in Participants 12 Years of Age and Older With Bronchiectasis and Chronic Pseudomonas Aeruginosa Colonization

Recruiting
NCT07712354Not Applicable1 site

High-Frequency Electroacupuncture at Cervical Huatuo Jiaji Points Combined With Electromagnetic Field Therapy for Cervical Spondylotic Radiculopathy

Recruiting
NCT05702034Phase 39 sites

A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE

Active Not Recruiting
NCT06677060Phase 311 sites

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

Recruiting
NCT05138133Phase 35 sites

Phase 3 Study of Anifrolumab in Adult Patients With Active Proliferative Lupus Nephritis

Active Not Recruiting
NCT07497087Phase 32 sites

A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis

Recruiting
NCT07060807Phase 31 site

A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

Recruiting
NCT04557462Phase 32 sites

A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy

Active Not Recruiting
NCT04606771Phase 23 sites

A Study Comparing Savolitinib Plus Osimertinib vs Savolitinib Plus Placebo in Patients With EGFRm+ and MET Amplified Advanced NSCLC

Active Not Recruiting
NCT06034743Phase 35 sites

A Study to Investigate the Efficacy and Safety of Baxdrostat in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants With Resistant Hypertension

Completed
NCT07727395Phase 39 sites

INtra-arterial AltEplase folloWing successfuL reperfusIoN After mEchanical Thrombectomy

Not Yet Recruiting
NCT06170788Phase 36 sites

Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)

Recruiting
NCT06134362Phase 31 site

Long-term Follow-up of Long-acting Cabotegravir (CAB LA) for PrEP (Pre-exposure Prophylaxis) in Participants at Risk of Acquiring HIV (Human Immunodeficiency Virus)

Active Not Recruiting
NCT03486873Phase 33 sites

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

Recruiting
NCT05739383Phase 32 sites

A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.

Active Not Recruiting
NCT07734987Not Applicable1 site

Accuracy and Healing Outcomes of Endodontic Surgery Using a Static Surgical Guide.

Recruiting
NCT04704999Phase 41 site

Southeast Asia Dose Optimization of Tafenoquine

Recruiting
NCT04736173Phase 22 sites

Study Evaluating Effectiveness and Safety of Zimberelimab and Domvanalimab in Lung Cancer

Active Not Recruiting